Stay updated on Magrolimab Combo in Untreated MDS: Clinical Trial
Sign up to get notified when there's something new on the Magrolimab Combo in Untreated MDS: Clinical Trial page.

Latest updates to the Magrolimab Combo in Untreated MDS: Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not pertain to the study, and updated the revision label from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check20 days agoChange DetectedGovernment funding/operating status notice at the top of the page was removed, and the study details remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedThe core study information (design, endpoints, eligibility, and outcomes) appears unchanged; differences observed are limited to page layout and display elements. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check63 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference2%

- Check70 days agoChange DetectedAdded revision tag v3.1.0 and removed several drug-safety subsections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs); versioning indicates a content update with potential consolidation of drug-safety topics.SummaryDifference0.2%

- Check84 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed; no other substantive changes detected.SummaryDifference0.1%

Stay in the know with updates to Magrolimab Combo in Untreated MDS: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab Combo in Untreated MDS: Clinical Trial page.